化工社化工社 化学情報印刷レポート · 研究参考用
Chloroquine → (2S)-2-methyl-N-((S)-1-phenylethyl)octanamide
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Chloroquine | HCID 2719 | — |
| 反応物 | Amphotericin B | HCID 5280965 | — |
| 反応物 | Nifurtimox | HCID 6842999 | — |
| 生成物 | (2S)-2-methyl-N-((S)-1-phenylethyl)octanamide | HCID 46237307 | — |
反応手順
Bioassays. All bioassays were performed in duplicate, testing at 10, 2, 0.4, 0.08 and 0.016 μg/mL. Malaria bioassays were performed as previously reported by our program, using chloroquine as a positive control (IC50=80-100 nM). Chagas bioassays were performed following the protocol of Buckner et al, and using nifurtimox as a positive control (IC50 3-5 μg/mL). Leishmaniasis bioassays were performed using a method previously employed in our laboratory, based on parasite DNA fluorescence. In this latter assay, amphotericin-B was used as the positive control and had an IC50 value of 80 ng/mL. Cytotoxicity bioassays were performed following an MTT cell proliferation assay protocol with green monkey Vero kidney cells.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08772247B2 |
| 出典データセット | uspto-grants-2014_07 |
| ORD ID | ord-5392fc785c8c4e4ebc7ac0bf9a4e3412 |
| 出典メモ | uspto-grants-2014_07 |